Page 140 - Multidisipliner Covid 19

BÖLÜM 08

21. Ridruejo E, Soza A. The liver in times of COVID-19: What hepatologists
should know. Ann Hepatol (2020), https://doi.org/10.1016/j.aohep.
2020.05.001.
22. D’Antiga L. Coronaviruses and immunosuppressed patients. The facts
during the third epidemic. Liver Transpl 2020, http://dx.doi.org/
10.1002/lt. 25756.
23. Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C.
Clini- cal course of COVID-19 in a series of patients with chronic arthri-
tis treated with immunosuppressive targeted therapies. Ann Rheum
Dis 2020;79:667–8, http://dx.doi.org/10.1136/annrheumdis-2020-
217424.
24. Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan
DC, et al. Clinical best practice advice for hepatology and liver transplant
providers during the COVID-19 pandemic: AASLD expert panel con-
sensus statement. Hepatology 2020, http://dx.doi.org/10.1002/hep.31281

139